Related Experiment Video
Updated: Mar 23, 2026
07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
955
Medical Comorbidities in Pediatric Headache
Howard Jacobs1, Samata Singhi2, Jack Gladstein3
1Department of Pediatrics, Ohio State University School of Medicine, Columbus, OH.
Seminars in Pediatric Neurology
|March 28, 2016
Summary
Pediatric headaches often coexist with other conditions, impacting treatment. Recognizing these comorbidities, such as ADHD and anxiety, helps neurologists tailor effective management strategies for children.
Area of Science:
- Neurology
- Pediatrics
- Clinical Medicine
Background:
- Comorbid conditions are common in pediatric headaches.
- These co-occurring conditions can complicate headache management in children.
- Identifying comorbidities is crucial for effective treatment.
Purpose of the Study:
- To review comorbidities associated with pediatric headaches.
- To provide child neurologists with information to identify common headache triggers.
- To guide the tailoring of management strategies for both headaches and comorbidities.
Main Methods:
- Literature review of studies on pediatric headache comorbidities.
- Synthesis of information on associated conditions like ADHD, autism, epilepsy, and IBD.
- Analysis of the impact of comorbidities on headache management.
Main Results:
- Common comorbidities include ADHD, autism, anxiety, epilepsy, and IBD.
- These conditions can influence headache presentation and treatment response.
- Management requires a comprehensive approach addressing all conditions.
Conclusions:
- Understanding comorbidities is essential for optimizing pediatric headache care.
- Child neurologists should screen for and manage associated conditions.
- Integrated management plans improve outcomes for children with headaches and comorbidities.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
322
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
443
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
678
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
369
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
01:29Drug Dosing: Infants and Children
720
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
720